Publications by authors named "Carlayne Jackson"

Claim this Profile
A
ALSUntangled #80: ISRIB (Integrated stress response InhiBitor).
Javier Mascias Cadavid, Anna Mena Bravo, Paul Barkhaus, Benjamin Barnes, Michael Benatar, Carlayne Jackson

Amyotroph Lateral Scler Frontotemporal Degener· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALSUntangled #81: Pyridostigmine (mestinon).
Nadia Mansoor, Terry Heiman-Patterson, Eva L Feldman, Paul Wicks, Michael Benatar, Carlayne Jackson

Amyotroph Lateral Scler Frontotemporal Degener· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.
Gang Wu, Wenan Chen, Joanne Wuu, Angita Jain, Jason Myers, Carlayne Jackson

Transl Neurodegener· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary progressive aphasia and amyotrophic lateral sclerosis (PPA-ALS): A longitudinal case study.
Gabrielle Hromas, Carlayne E Jackson, Douglas B Cooper, A Campbell Sullivan

Appl Neuropsychol Adult· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment.
Angela Genge, Gary L Pattee, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E Jackson

Muscle Nerve· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALSUntangled #78: Zinc.
Benjamin Helmold, George Nathaniel, Paul Barkhaus, Tulio Bertorini, Mark Bromberg, Carlayne Jackson

Amyotroph Lateral Scler Frontotemporal Degener· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurology in the Twenty-First Century.
John D England, Ann C Tilton, Carlayne E Jackson

Ann Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALSUntangled #77: Psilocybin.
Bhavya Bakshi, Sandeep Yerraguntla, Carmel Armon, Paul Barkhaus, Tulio Bertorini, Carlayne Jackson

Amyotroph Lateral Scler Frontotemporal Degener· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALSUntangled #79: alpha-lipoic acid.
Alaina Giacobbe, James Hiana, Olivia Wang, Michael Benatar, Paul Wicks, Carlayne Jackson

Amyotroph Lateral Scler Frontotemporal Degener· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.

JAMA Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALSUntangled #76: Wahls protocol.
Xiaoyan Li, Paul Wicks, Andrew Brown, Akhil Shivaprasad, Maxwell Greene, Carlayne Jackson

Amyotroph Lateral Scler Frontotemporal Degener· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevating the wellbeing of neurologists.
Neil A Busis, Jennifer Bickel, Carlayne E Jackson

Lancet Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, Lori B Chibnik, Melanie Quintana, Carlayne E Jackson

JAMA Netw Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effectiveness of medical marijuana in patients with amyotrophic lateral sclerosis.
John Michael Austin, Ryan Bailey, Sandra Garcia Velazquez, Harinandan Sainath, Carlayne Jackson

J Neurol Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual Intimacy in Persons with Amyotrophic Lateral Sclerosis and their Partners: A Pilot Study.
Victoria Ramirez, Pamela Kittrell, Carlayne Jackson, Autumn Clegg, Ana Allegretti

J Allied Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALSUntangled #75: Portable neuromodulation stimulator therapy.
Laurel Officer, Carmel Armon, Paul Barkhaus, Morgan Beauchamp, Michael Benatar, Carlayne Jackson

Amyotroph Lateral Scler Frontotemporal Degener· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Edaravone - Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis.
Gary L Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Carlayne E Jackson

Expert Rev Neurother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
Jeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews, Adriano Chio, Mamede De Carvalho, Carlayne E Jackson

Amyotroph Lateral Scler Frontotemporal Degener· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
Paulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, Phil Sarocco, Jenny Wei, Carlayne E Jackson

Amyotroph Lateral Scler Frontotemporal Degener· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving or placebo in FORTITUDE-ALS.
Paulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, Phil Sarocco, Jenny Wei, Carlayne E Jackson

J Med Econ· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment.
Angela Genge, Gary L Pattee, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E Jackson

Muscle Nerve· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial.
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, Newman Knowlton, James D Berry, Carlayne Jackson

J Neurol Neurosurg Psychiatry· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Futures Planning at the AAN: Approach and Initial Outcome.
Carlayne E Jackson, Lyell K Jones, Brad C Klein, Natalia R Rost, Sarah M Benish

Neurology· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis